Sign in
Taking peoplePhase 2

Gamma Knife radiosurgery very early in trigeminal neuralgia, a facial pain condition

Tests Gamma Knife radiosurgery given very early to adults with trigeminal neuralgia.

Key facts

Who runs it
University of Alberta
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN
Status
Recruiting
Phase
Phase 2
People taking part
80 people, planned
Started
30 Jul 2025
Expected to end
1 May 2032
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • GK SRS
Record updated
23 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults diagnosed with classical or idiopathic trigeminal neuralgia (facial nerve pain) in the last 2 years. It compares early Gamma Knife radiosurgery with usual medicine treatment.

Age
18 years or older
Sex
All sexes
Disease stage
Classical or idiopathic trigeminal neuralgia, diagnosed from clinical history and MRI scan within 2 years before joining. Pain must not be resistant to medicines (adequate pain control despite 2 or more medicine trials).
Earlier treatment
People cannot join if they had surgery for trigeminal neuralgia or radiation to the head or neck. If taking medicine now, the dose must have been stable for at least 3 months.

Main reasons for not taking part

  • Trigeminal neuralgia caused by another condition (secondary), or pain on both sides of the face
  • Any reason they cannot have Gamma Knife radiosurgery
  • Past radiation to the head or neck, or past surgery for trigeminal neuralgia
  • A psychiatric diagnosis within 2 years, or uncontrolled mental illness
  • Pregnant or breast-feeding women

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age ≥18 years
  • Clinical diagnosis of classical or idiopathic TN, based on clinical history and MRI scan
  • Clinical diagnosis within 2 years prior to enrolment
  • Not deemed medically refractory (defined as adequate pain control despite ≥2 medication trials of adequate dose. Adequate pain control is defined as pain that is considered acceptably controlled by both the patient and treating neurologist, without the need for further dose escalation)
  • If currently on medication, on stable dose x at least 3 months

Who cannot take part

  • Any prior surgical intervention for TN
  • History of psychiatric diagnoses within 2 years of study participation, or uncontrolled, concurrent psychiatric illness (e.g., depression with recent suicide attempts)
  • Any history of head and/or neck radiation therapy
  • Secondary TN
  • Bilateral TN
  • Any contraindications to undergoing GK-SRS
  • Females who are pregnant or breast-feeding

This trial is currently available in Canada.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate Gamma Knife stereotactic radiosurgery (GK-SRS) as an ultra-early treatment option for trigeminal neuralgia (TN).

Read full original descriptionShow less

The main questions it aims to answer are:

1. will earlier GK-SRS provide more durable pain relief compared to later GK-SRS? 2. will earlier GK-SRS reduce or eliminate the need for high-dose medical therapy? 3. will earlier GK-SRS have a lower risk of serious complications compared to other first-line treatments?

If participants are assigned to GK-SRS treatment group, they will be asked to:

• Undergo a preoperative MRI, measurements of heart rate and blood pressure, stereotactic head-frame placement, post-operative management and observation.

Both groups will be asked to:

* Complete medical histories and neurological examinations. These are part of standard of care. * Participants will be asked a series of questions related to overall physical health, pain severity, and mood. Completing these questionnaires is part of the research activity. It will take approximately 15- 30 minutes to complete. These questionnaires include: The Barrow Neurological Institute Pain Intensity Score, Brief Pain Inventory-Facial (BPI-Facial), Visual Analog Scale (VAS), Medication Quantification Scale (MQS), Hospital Anxiety and Depression Scale (HADS), Pain Catastrophizing Scale (PCS), and the Short Form Health Survey.

The 2 groups in the trial

  • Standard armNo study treatment, for comparison

    Patients allocated to the standard arm will continue their medical management per the judgment of treating physician.

  • Gamma Knife stereotactic radiosurgery for TNTreatment being tested

    Treatment: GK SRS

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Ultra-early Gamma Knife Stereotactic Radiosurgery for Trigeminal Neuralgia
Plain-language title
Gamma Knife radiosurgery very early in trigeminal neuralgia, a facial pain conditionGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Publications
Record updated
23 October 2026